Machine learning is revolutionizing cancer drug discovery. Dr Bissan Al-Lazikani, head of data science at the Institute of Cancer Research, explains how the technology is adding a new dimension to the fight against the disease.
Tailored medical treatment is tantalisingly close now that medical practitioners are able to collect, analyze and learn from petabytes of individual patient data. The Institute of Cancer Research’s head of data science reveals what this will mean for cancer treatment.
Dr Bissan Al-Lazikani, head of data science at The Institute of Cancer Research, reveals how the capability to integrate and analyze vast volumes of data is playing a vital role in the discovery of effective cancer drugs.